TM Capital assisted Immucor, Inc. (NASDAQ) in completing the $30 million acquisition of Gamma Biologicals, Inc. (AMEX) via a cash tender offer
TM Capital advised Immucor, Inc. (NASDAQ) on its $117 million acquisition of BioArray Solutions Ltd.
TM Capital served as exclusive financial advisor to Sapheon Inc., a developer of venous disease treatments, in its sale to Covidien plc, a world leader in the treatment of peripheral vascular disease, for up to $238 million in cash and contingent consideration
TM Capital assisted in the sale of Transart Educational Marketing Services Ltd. to Sudler & Hennessey, a subsidary of Young & Rubicam Inc.
TM Capital assisted The MedTech Group in completing a recapitalization with KRG Capital Partners to accelerate growth and provide shareholder liquidity